Target (CBDY) Share-based Compensation (2015 - 2023)
Target (CBDY) reported Share-based Compensation of $635.0 for Q3 2023, up 5391.67% year-over-year from $11.56 in Q3 2022, and up 1816.22% quarter-over-quarter from -$37.0 in Q2 2023.
Target (CBDY) Share-based Compensation (2015 - 2023) Analysis & Trends
Target (CBDY) has 9 years of Share-based Compensation data on file, last reported at $635.0 in Q3 2023.
- Share-based Compensation for Q3 2023 came in at $635.0, up 5391.67% year-over-year; the trailing twelve-month figure through Dec 2023 was $821.0 (down 50.54% YoY), and the FY2023 annual result was $821.0, down 50.54% from the prior year.
- Share-based Compensation grew to $635.0 in Q3 2023 per CBDY's latest filing, from -$37.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $636000.0 in Q4 2019 and troughed at -$1012.0 in Q4 2020.
- A 5-year average of $40576.9 and a median of $609.0 in 2022 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2022 and 2023: Share-based Compensation plunged 112.89% in 2022, then soared 5391.67% in 2023.
- A 5-year view of Share-based Compensation shows it stood at $636000.0 in 2019, then slumped by 100.16% to -$1012.0 in 2020, then jumped by 170.26% to $711.0 in 2021, then surged by 76.09% to $1252.0 in 2022, then slumped by 49.28% to $635.0 in 2023.
- Business Quant data shows CBDY's Share-based Compensation at $635.0 in Q3 2023, -$37.0 in Q2 2023, and $223.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 43.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 25.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 33.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -395,114.54 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 57.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 21.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 36.33 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 36.86 Mn |
| 10 | Target | - | - | 191,787.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 635.00 |
| Sep 30, 2023 | 635.00 |
| Jun 30, 2023 | -37.00 |
| Jun 30, 2023 | -37.00 |
| Mar 31, 2023 | 223.00 |
| Mar 31, 2023 | 223.00 |
| Dec 31, 2022 | 1,252.00 |
| Dec 31, 2022 | 1,252.00 |
| Sep 30, 2022 | -12.00 |
| Sep 30, 2022 | -12.00 |
| Jun 30, 2022 | -163.00 |
| Jun 30, 2022 | -163.00 |
| Mar 31, 2022 | 583.00 |
| Mar 31, 2022 | 583.00 |
| Dec 31, 2021 | 711.00 |
| Dec 31, 2021 | 711.00 |
| Sep 30, 2021 | 1,087.00 |
| Sep 30, 2021 | 1,087.00 |
| Jun 30, 2021 | 1,265.00 |
| Jun 30, 2021 | 1,265.00 |